The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo

International Journal of Cancer

Volumn 124, Issue 10, 2009, Pages 2488-2494

  Schulte, Johannes H ^a   Pentek, Falk ^a   Hartmann, Wolfgang ^b   Schramm, Alexander ^a   Friedrichs, Nicolaus ^b   Øra, Ingrid ^c,d   Koster, Jan ^d   Versteeg, Rogier ^d   Kirfel, Jutta ^b   Buettner, Reinhard ^b   Eggert, Angelika ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

CD271; Low affinity neurotrophin receptor; Neuroblastoma; p75; TMA

Indexed keywords

MESSENGER RNA; NEUROTROPHIN RECEPTOR P75; NERVE GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENICITY; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GANGLIONEUROMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY; TISSUE STRUCTURE; UPREGULATION; ANIMAL; COHORT ANALYSIS; FLOW CYTOMETRY; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COHORT STUDIES; FLOW CYTOMETRY; GANGLIONEUROBLASTOMA; GANGLIONEUROMA; HUMANS; MICE; MICE, NUDE; RECEPTOR, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; UP-REGULATION;

EID: 64249131067     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24204     Document Type: Article

References (35)

1. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-16.
2. Maris JM, Courtright J, Houghton PJ, Morton CL, Gorlick R, Kolb EA, Lock R, Tajbakhsh M, Reynolds CP, Keir ST, Wu J, Smith MA. Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program. Pediatr Blood Cancer 2008;50:581-7.
3. Nakagawara A. Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett 2001;169:107-14.
4. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000;10:381-91.
5. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993;328:847-54.
6. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 1994;14:759-67.
7. Schramm A, Schulte JH, Astrahantseff K, Apostolov O, Limpt VV, Sieverts H, Kuhfittig-Kulle S, Pfeiffer P, Versteeg R, Eggert A. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Lett 2005;228:143-53.
8. Bunone G, Mariotti A, Compagni A, Morandi E, Della Valle G. Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells. Oncogene 1997;14:1463-70.
9. Chen J, Zhe X. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells. Chin Med J (Engl) 2003;116:906-12.
10. Eggert A, Sieverts H, Ikegaki N, Brodeur GM. p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA. Med Pediatr Oncol 2000;35:573-6.
11. Fanburg-Smith JC, Miettinen M. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues. Hum Pathol 2001;32:976-83.
12. Lievremont JP, Sciorati C, Morandi E, Paolucci C, Bunone G, Della Valle G, Meldolesi J, Clementi E. The p75(NTR)-induced apoptotic program develops through a ceramide-caspase pathway negatively regulated by nitric oxide. J Biol Chem 1999;274:15466-72.
13. Riboni L, Prinetti A, Bassi R, Caminiti A, Tettamanti G. A mediator role of ceramide in the regulation of neuroblastoma Neuro2a cell differentiation. J Biol Chem 1995;270:26868-75.
14. Teng KK, Hempstead BL. Neurotrophins and their receptors: signaling trios in complex biological systems. Cell Mol Life Sci 2004;61:35-48.
15. Underwood CK, Coulson EJ. The p75 neurotrophin receptor. Int J Biochem Cell Biol 2008;40:1664-8.
16. Hennigan A, O'Callaghan RM, Kelly AM. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem Soc Trans 2007;35:424-7.
17. Rocha AS, Risberg B, Magalhaes J, Trovisco V, de Castro IV, Lazarovici P, Soares P, Davidson B, Sobrinho-Simoes M. The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma. Hum Pathol 2006;37:562-8.
18. Krygier S, Djakiew D. Molecular characterization of the loss of p75(NTR) expression in human prostate tumor cells. Mol Carcinog 2001;31:46-55.
19. Guate JL, Fernandez N, Lanzas JM, Escaf S, Vega JA. Expression of p75(LNGFR) and Trk neurotrophin receptors in normal and neoplastic human prostate. BJU Int 1999;84:495-502.
20. Marchetti D, Aucoin R, Blust J, Murry B, Greiter-Wilke A. p75 neurotrophin receptor functions as a survival receptor in brain-metastatic melanoma cells. J Cell Biochem 2004;91:206-15.
21. Kanik AB, Yaar M, Bhawan J. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Cutan Pathol 1996;23:205-10.
22. Jin H, Pan Y, Zhao L, Zhai H, Li X, Sun L, He L, Chen Y, Hong L, Du Y, Fan D. p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia 2007;9:471-8.
23. Dimaras H, Gallie BL. The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development. Int J Cancer 2008;122:2023-9.
24. Stephan H, Zakrzewski JL, Boloni R, Grasemann C, Lohmann DR, Eggert A. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines. Pediatr Blood Cancer 2008;50:218-22.
25. Dimaras H, Coburn B, Pajovic S, Gallie BL. Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma. Mol Carcinog 2006;45:333-43.
26. Johnston AL, Lun X, Rahn JJ, Liacini A, Wang L, Hamilton MG, Parney IF, Hempstead BL, Robbins SM, Forsyth PA, Senger DL The p75 neurotrophin receptor is a central regulator of glioma invasion. PLoS Biol 2007;5:e212.
27. Maurer J, Fuchs S, Jager R, Kurz B, Sommer L, Schorle H. Establishment and controlled differentiation of neural crest stem cell lines using conditional transgenesis. Differentiation 2007;75:580-91.
28. Hansford LM, McKee AE, Zhang L, George RE, Gerstle JT, Thorner PS, Smith KM, Look AT, Yeger H, Miller FD, Irwin MS, Thiele CJ, Kaplan DR. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 2007;67:11234-43.
29. Schulte JH, Schramm A, Klein-Hitpass L, Klenk M, Wessels H, Hauffa BP, Eils J, Eils R, Brodeur GM, Schweigerer L, Havers W, Eggert A. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas. Oncogene 2005;24:165-77.
30. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP. The International neuroblastoma pathology classification (the Shimada system). Cancer 1999;86:364-72.
31. Ambros IM, Zellner A, Roald B, Amann G, Ladenstein R, Printz D, Gadner H, Ambros PF. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 1996;334:1505-11.
32. Ambros IM, Zellner A, Stock C, Amann G, Gadner H, Ambros PF. Proof of the reactive nature of the Schwann cell in neuroblastoma and its clinical implications. Prog Clin Biol Res 1994;385:331-7.
33. Mora J, Akram M, Cheung NK, Chen L, Gerald WL. Laser-capture microdissected schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterations. Med Pediatr Oncol 2000;35:534-7.
34. Sinnappah-Kang ND, Mrak RE, Paulsen DB, Marchetti D. Heparanase expression and TrkC/p75NTR ratios in human medulloblastoma. Clin Exp Metastasis 2006;23:55-63.
35. Wong CE, Paratore C, Dours-Zimmermann MT, Rochat A, Pietri T, Suter U, Zimmermann DR, Dufour S, Thiery JP, Meijer D, Beermann F, Barrandon Y, et al. Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin. J Cell Biol 2006;175:1005-15.